Metabolic Regulation of Tumor Microenvironment with Biohybrid Bacterial Bioreactor for Enhanced Cancer Chemo‐Immunotherapy

Ziyi Han, Cheng Zhang, Jia‐Xin An, Yu‐Zhang Wang, Jiyan Qiao, Xuan Zeng, Xian‐Zheng Zhang

Advanced Functional Materials · 2023 · 48 citations · 28 references

Concepts

Abstract

Abstract Immunogenic cell death (ICD) induced by specific chemotherapeutic agents is often hampered by the immunosuppressive tumor microenvironment (TME). Here, a bacterial bioreactor E@Fe‐DOX, is developed, to enhance ICD‐mediated antitumor immunity by in situ manipulation of tumor metabolism‐immune interactions. The E@Fe‐DOX bioreactor is constructed by depositing doxorubicin‐loaded iron‐polyphenol nanoparticles on Eubacterium hallii , which can specifically target hypoxic tumor regions and release doxorubicin and Fe 3+ to induce ICD. In addition, Eubacterium hallii can continuously convert intratumoral lactate to butyrate, which inhibits the polarization of pro‐tumoral M2‐like macrophages and improves the function of tumor‐infiltrating cytotoxic T cells. Furthermore, E@Fe‐DOX promotes the formation of immune cell‐aggregated tertiary lymph structures (TLS) to augment ICD‐induced antitumor immunity. In murine tumor models, E@Fe‐DOX significantly inhibits tumor growth and enhances immune checkpoint blockade (ICB) therapy. Overall, the developed living biomaterial offers a promising strategy to potentiate cancer chemo‐immunotherapy by continuously regulating the intratumoral immuno‐metabolic microenvironment.

References

28